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Abstract 
In March, 2003, the editor of The Lancet attended an international conference in 
Kingston, Ontario, Canada, on primary-care research, subsequently running a rather 
dyspeptic editorial entitled "Is primary-care research a lost cause?"1 This article 
highlighted the unacceptable weakness of primary-care research worldwide. A particular 
concern of the conference was the shortage of primary care research in less economically 
developed countries to inform the clinical and public health management of malnutrition, 
malaria, AIDS, water-borne infection, and other illnesses of poverty.2 However, problems 
exist even in economically developed countries. In Australia, for example, a crude 
measure of research productivity with practising physicians as the denominator suggests 
that primary care is only 1% as productive as internal medicine, 0.5% as productive as 
public health and 1.6% as productive as surgery.3 But for The Lancet to characterise 
primary-care research as a "lost cause" is unhelpful. This notion implies either that the 
field is so weak that it cannot be resuscitated or that it is irrelevant anyway. Both are 
wrong.
Primary care needs an evidence base
Research in primary care is essential because: (1) clinical and preventive care must be 
underpinned by research evidence; (2) the bulk of such care in most countries, especially 
poorer countries, is delivered in primary care; and (3) evidence to underpin this care (for 
example, the diagnosis and appropriate management of headache, vomiting, rashes, 
diarrhoea, fever, joint pains, chest pain, abdominal pain, cough, breathlessness, vaginal 
bleeding-the list is long and ranges across all specialist areas) cannot be informed by 
laboratory and hospital-based research alone.4 Absence of research in primary care will 
lead to over-investigation, inappropriate treatment, and diagnostic delay through wrong-
track referral. For example, it was estimated in 1994 that the implementation in primary 
care of the National Institutes of Health consensus guidelines on the management of 
headache would add US$2 billion to the annual US health budget; similarly, the shortage 
of an adequate evidence base for the use of antibiotics in primary care was estimated to 
cost at least $50 million a year in the USA and to contribute to the global problem of 
antibiotic resistance.5
Primary-care research should focus on clinical practice
The Lancet editorial suggested that the focus of primary- care research should be the 
family. This is a serious misunderstanding. The main function of primary-care research is 
to inform clinical practice in primary care. A government review in the UK characterised 
the research need in terms of four "evidence gaps"-about the effectiveness of 
interventions delivered mainly in primary care, the applicability of hospital-based 
research to primary care, the implementation of best evidence in primary-care practice, 
and the basic science of illness and its care in the community.6 Similarly, the Dutch 
government has commissioned a specific national research council programme to bridge 
the evidence gaps made apparent by the development of national guidelines for the 
management of common conditions in primary care, essential elements of which had to 
be based on opinion because of a lack of a rigorous research base.7-9 
Primary-care research can affect clinical practice
These governmental decisions to support and develop primary-care research were 
affected by the observation that high-quality research that influences clinical practice can 
be done successfully in primary care. This is particularly clear in relation to the 
management of conditions seen only in primary care. For example, publication of the 
results of the first primary-care-based treatment trial of otitis media in children over 20 
years ago10 revolutionised the clinical management of this disease in the Netherlands; the 
Cochrane review of subsequent general practice trials of antibiotic treatment of otitis 
media11 now provides the evidence base for clinical care of this condition internationally. 
The success of primary-care research is also especially clear in relation to disease 
prevention. For example, more than half the observed reduction in coronary heart disease 
mortality has been attributed to primary and secondary prevention,12 and many of the 
clinical trials underpinning preventive care of this and other important public health 
problems were done in a primary-care setting.13-15 The primary-care-based Cochrane 
smoking addiction review group, which was stimulated by an early review done by 
researchers involved in the general practice smoking cessation trials,16 now provides the 
evidence-base that underpins governmental policy internationally. And primary care is an 
important player in the internationally important field of vaccine research.17
The effect of primary-care research on chronic disease is perhaps more difficult to tease 
out because applied clinical research also takes place in a hospital setting. However, a 
substantial number of important and clinically relevant trials and cohort studies have been 
published by primary-care based researchers in relation to all the common chronic 
conditions managed in primary care, including back pain,18 asthma,19 cancer,20 heart 
failure,21 diabetes,22 and depression.23 Primary care has taken a lead in developing the 
methodology of applied clinical research to assess the effectiveness of complex health 
service interventions.24,25 There are increasingly influential and important bodies of work 
being undertaken in relation to the diagnosis, monitoring, and long-term care of illness 
outside hospital.26,27 It was probably also relevant to the investment decision of the UK 
and Dutch governments that several universities in the UK and the Netherlands do 
primary-care research that is assessed as equating to the best attainable levels of 
international excellence in any discipline and compete on equal terms with all other 
medical science disciplines.28,29
Achieving high quality primary-care research
Achievement of excellence in clinical research depends above all on recruitment of the 
most able and committed people to the discipline. In many countries, primary care is still 
perceived as second class,30 and the academic career structure in primary care is often 
notable for its financial and career insecurity. This problem will not be easily overcome 
without government intervention at a national level to address barriers to recruitment and 
retention, and this will not be a short-term fix. Once some of the brightest and best have 
been recruited, reaching the point of self-sustained growth in research still needs 
affirmative action by funding agencies. These agencies, including the non-governmental 
medical charities, need to divert just a small fraction of their resources to have a 
substantial effect. One strategy would be to develop primary-care expertise alongside 
existing centres of research excellence in other disciplines. However, it requires long-
term funding of core staff, not just short-term project funding even if ring-fenced. Most 
primary-care researchers still do not have the core infrastructure funding and career 
security which underpins the accrual of high-level research expertise in a subject area and 
allows the development work that produces the highest quality grant applications.
Achieving integration with clinical care
High-quality applied clinical research requires integration of research into clinical 
services. Primary care is certainly not unique in this requirement-the freedom with which 
clinicians of all disciplines can make evidence-free clinical judgments contrasts starkly 
with the barriers to undertaking research to supply the evidence.31 For example, we can 
contribute to the global problem of antibiotic resistance by prescribing antibiotics for 
common viral infections without accountability or constraint, but the barriers to 
prescribing the drugs as part of a research study to address this problem are immense. 
Health-service managers are often short-sightedly intolerant of the increased clinic and 
consultation time required for research and informed consent. Governments need to make 
a strategic decision to embed research within a health-care system to allow primary-care 
research (and applied clinical research in hospitals) to take place. The pay-off from this 
investment is not simply the production of research evidence. Good, motivated primary-
care clinicians in any health-care system want to reflect and improve on what they do 
(that is, to engage in research) and we believe that it is self-evident that encouraging this 
activity promotes the recruitment and retention of good doctors and stimulates the 
implementation of evidence-based best practice.
Conclusion
Primary-care research is not a lost cause. It is an important cause. Effective prevention in 
primary care avoids serious diseases. No disease can be cured unless someone, usually in 
primary care, first recognises it. No long-term treatment works unless it is administered 
effectively, again often in primary care. All these clinical activities need the leadership, 
reflection, and underpinning evidence that primary-care research provides. The strength 
of primary-care research in any country is probably a good indicator of the strength and 
quality of primary care in that country.
However, the weaknesses highlighted by The Lancet need to be taken seriously, 
especially in countries where primary care is all there is. Medical charities, as well as 
government agencies, could and should play a much stronger role. But above all it is 
incumbent on the researchers themselves to continue to show that they make a difference 
to the quality of care. Investment in research in primary care must be recognised not only 
as an investment in the generation of clinical evidence, but also an investment in clinical 
leadership and service quality.
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